TORONTO, April 28, 2025 ( GLOBE NEWSWIRE ) -- Matador Technologies Inc. ( "Matador" or the "Company" ) ( TSXV: MATA, OTCQB: MATAF ) , a Bitcoin Ecosystem company, is pleased to announce that the Company's stock ticker symbol on the OTCQB Venture Market ( the "OTCQB" ) will change from "MTDTF" to ...

Approval Supports Revenue Growth and Margin Expansion Opportunity, and Substantially Increases Peak Production Output Capacity First U.S. Regulatory Approval of Innovative IG Yield Enhancement Process Highlights ADMA's Uniquely Efficient Internal R&D Engine, Spanning Production and Product ...

WATERTOWN, Mass., April 28, 2025 ( GLOBE NEWSWIRE ) -- Neumora Therapeutics, Inc. NMRA, a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven brain disease programs including two clinical-stage programs, today announced that it will host a conference call and ...

VYJUVEK approved for the treatment of DEB from birth in Europe Approval allows for dosing at home or in a healthcare setting, as well as patient or caregiver administration if deemed appropriate by a healthcare professional

PORTLAND, Ore., April 28, 2025 ( GLOBE NEWSWIRE ) -- Widmer Brothers Brewing, the creator of the Original American Hefeweizen and a Tilray Brands, Inc., TLRYTLRY craft beer brand, commemorates its 40th anniversary with the launch of the "40 Years of Cheers" campaign celebrating Widmer's iconic ...

NEW YORK, April 28, 2025 ( GLOBE NEWSWIRE ) -- Syndax Pharmaceuticals SNDX, a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that it will report its first quarter 2025 financial results and provide a business update on Monday, ...

CALGARY, Alberta, April 28, 2025 ( GLOBE NEWSWIRE ) -- Benevity Inc. today announced the appointment of Ian Goldsmith as Chief Artificial Intelligence ( AI ) Officer, the first such dedicated role in the corporate social responsibility ( CSR ) and social impact software industry.

NEWTON, Mass., April 28, 2025 ( GLOBE NEWSWIRE ) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced preclinical data in prostate cancer at the American Association for ...

Data presented at the American Association for Cancer Research ( AACR ) Annual Meeting 2025 Dose Finding completed with no dose limiting toxicities and preliminary recommended Phase 2 dose ( RP2D ) identified

MILAN, April 28, 2025 ( GLOBE NEWSWIRE ) -- AAVantgarde Bio ( AAVantgarde ) , a clinical-stage, international biotechnology company with two proprietary Adeno-Associated Viral ( AAV ) vector platforms for large gene delivery, today announced the appointment of Mr. Rasmus Holm-Jorgesen as their ...